WARNING: These algorithms have been developed as a guide to our residents especially for initial empirical therapeutic approach and prophylaxis. They are updated periodically. Recommendations for antimicrobials are based on the local pathogen and resistance profiles in our hospital. Therefore, it is not recommended to apply them in another institution word by word. 

7.1.a Antibacterial Prophylaxis

7.1.b Antifungal Prophylaxis

7.1.b.1. Tables for Antifungal Prophylactic Approach in Special Conditions

7.1.c Antiviral Prophylaxis

7.2. Initial Evaluation of the Febrile Neutropenic Patient

7.3. Clinical & Lab Parameters of the Febrile Neutropenic Patient and the MASCC Score

7.4a. Initial Empirical Antibacterial Treatment in the Low-Risk Febrile Neutropenic Patient

7.4b Initial Empirical Treatment of Febrile Neutropenia in the High-Risk Febrile Neutropenic Patient

7.4c Initial Empirical Antibacterial Treatment in the High-Risk Febrile Neutropenic Patient with Type 1 Penicillin Hypersensitivity

7.5. Empirical Treatment Against Gram (+) Bacteria in the Febrile Neutropenic Patient

7.6. Follow-up of the Febrile Neutropenic Patient

7.7. Treatment & Follow-up of anti-Mold Treatment in the Neutropenic Host

7.8. SOFA Score

7.9. Quality Indicators in the Management of Febrile Neutropenia

7.10. EQUAL Aspergillosis Score

7.11. TDM Available in the Central Hospital Lab

7.12. Vaccination Recommendations for Patients with Hematological Malignancies or HSCT

7.13. WHO AWaRe Antibiotic List